Literature DB >> 18606698

Selective activation of human intestinal mast cells by Escherichia coli hemolysin.

Sigrid Krämer1, Gernot Sellge, Axel Lorentz, Dagmar Krueger, Michael Schemann, Katharina Feilhauer, Florian Gunzer, Stephan C Bischoff.   

Abstract

Mast cells (MCs) are recognized to play an important role in bacterial host defense in the murine system. In this study, we studied the interaction of human MCs, isolated from the intestine and purified to homogeneity, with different Escherichia coli and Shigella flexneri strains. We show that alpha-hemolysin (Hly)-producing E. coli strains induce the release of histamine, leukotrienes, and proinflammatory cytokines in intestinal MCs. In contrast, MCs were virtually unresponsive to S. flexneri and several Hly-negative E. coli strains, including the isogenic Hly-deficient mutants of Hly(+) strains. Hly(+) E. coli but not Hly(-) E. coli caused an increase in intracellular Ca(2+) levels. Blocking of extracellular Ca(2+) and of the calmodulin/calcineurin pathway by cyclosporin A inhibited the response to Hly(+) E. coli. Furthermore, inhibition of MAPKs p38 and ERK reduces activation of MCs by Hly(+) E. coli. In addition, using an ex vivo system, we directly record the histamine release by MCs located in the lamina propria after infection with Hly(+) E. coli. Our data indicate that human intestinal mast cells interact with selected Gram-negative bacteria, establish E. coli Hly as a factor regulating MC effector functions, and argue further for a role of human MCs in innate immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606698     DOI: 10.4049/jimmunol.181.2.1438

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats.

Authors:  Hirokazu Sato; Linda S Zhang; Kristina Martinez; Eugene B Chang; Qing Yang; Fei Wang; Philip N Howles; Ryota Hokari; Soichiro Miura; Patrick Tso
Journal:  Gastroenterology       Date:  2016-07-18       Impact factor: 22.682

Review 2.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

3.  Soluble CD14 is essential for lipopolysaccharide-dependent activation of human intestinal mast cells from macroscopically normal as well as Crohn's disease tissue.

Authors:  Sibylle A Brenner; Steffi Zacheja; Michael Schäffer; Katharina Feilhauer; Stephan C Bischoff; Axel Lorentz
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

4.  Diversity of intestinal bifidobacteria in patients with Japanese cedar pollinosis and possible influence of probiotic intervention.

Authors:  Akira Kubota; Fang He; Manabu Kawase; Gaku Harata; Masaru Hiramatsu; Hisakazu Iino
Journal:  Curr Microbiol       Date:  2010-05-29       Impact factor: 2.188

5.  Protease-activated receptor 2 has pivotal roles in cellular mechanisms involved in experimental periodontitis.

Authors:  David M Wong; Vivian Tam; Roselind Lam; Katrina A Walsh; Liliana Tatarczuch; Charles N Pagel; Eric C Reynolds; Neil M O'Brien-Simpson; Eleanor J Mackie; Robert N Pike
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

Review 6.  Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Ramon Alfonso Exeni; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Gabriela Alejandra Fiorentino; Andrea Mariana Exeni; Maria Victoria Ramos; Marina Sandra Palermo
Journal:  Pediatr Nephrol       Date:  2018-01-25       Impact factor: 3.714

Review 7.  Physiological and pathophysiological functions of intestinal mast cells.

Authors:  Stephan C Bischoff
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 8.  Mast cells: multitalented facilitators of protection against bacterial pathogens.

Authors:  Nikita H Trivedi; M Neal Guentzel; Annette R Rodriguez; Jieh-Juen Yu; Thomas G Forsthuber; Bernard P Arulanandam
Journal:  Expert Rev Clin Immunol       Date:  2013-02       Impact factor: 4.473

9.  'Gut health': a new objective in medicine?

Authors:  Stephan C Bischoff
Journal:  BMC Med       Date:  2011-03-14       Impact factor: 8.775

Review 10.  Molecular Mechanisms of Mast Cell Activation by Cholesterol-Dependent Cytolysins.

Authors:  Lubica Draberova; Magda Tumova; Petr Draber
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.